{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:18:09Z","timestamp":1792603089001,"version":"4.5.0"},"reference-count":64,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Phosphatidylcholine (PC) is an essential lipid for liver health and lipoprotein metabolism, but its circulating levels have rarely been studied in patients with cirrhosis. Chronic hepatitis C virus (HCV) infection causes lipid abnormalities and is a major cause of cirrhosis. Effective HCV elimination with direct-acting antivirals (DAAs) is associated with the normalization of serum low-density lipoprotein cholesterol levels. Since PC is abundant in all lipoprotein particles, this study analyzed the association between serum PC species levels and liver cirrhosis before and after HCV eradication. Therefore, 27 PC species were measured by Fourier Transform Mass Spectrometry in the serum of 178 patients with chronic HCV infection at baseline and in 176 of these patients at the end of therapy. The PC species did not correlate with viral load, and the levels of 13 PC species were reduced in patients infected with genotype 3a compared to those affected with genotype 1. Four PC species were slightly elevated 12 weeks after DAA initiation, and genotype-related changes were largely normalized. Patients with HCV and cirrhosis had higher serum levels of PC 30:0 and 32:0 before and at the end of therapy. PC species containing polyunsaturated fatty acids were mostly decreased in cirrhosis. The levels of polyunsaturated, but not saturated, PC species were inversely correlated with the model of the end-stage liver disease score. A receiver operating characteristic curve analysis showed area under the curve values of 0.814 and 0.826 for PC 32:0 and 0.917 and 0.914 for % PC 32:0 (relative to the total PC levels) for the classification of cirrhosis at baseline and at the end of therapy, respectively. In conclusion, the specific upregulation of PC 32:0 in cirrhosis before and after therapy may be of diagnostic value in HCV-related cirrhosis.<\/jats:p>","DOI":"10.3390\/ijms25158161","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T09:22:42Z","timestamp":1721985762000},"page":"8161","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Serum Phosphatidylcholine Species 32:0 as a Biomarker for Liver Cirrhosis Pre- and Post-Hepatitis C Virus Clearance"],"prefix":"10.3390","volume":"25","author":[{"given":"Kilian","family":"Weigand","sequence":"first","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"},{"name":"Department of Gastroenterology, Gemeinschaftsklinikum Mittelrhein, 56073 Koblenz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Peschel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"},{"name":"Department of Internal Medicine, Klinikum F\u00fcrstenfeldbruck, 82256 F\u00fcrstenfeldbruck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Grimm","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"H\u00f6ring","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Krautbauer","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Liebisch","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5635-3994","authenticated-orcid":false,"given":"Christa","family":"Buechler","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/hep.20030","article-title":"Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth","volume":"39","author":"Casiraghi","year":"2004","journal-title":"Hepatology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3748\/wjg.v22.i6.1953","article-title":"Hepatitis C virus relies on lipoproteins for its life cycle","volume":"22","author":"Grassi","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Sidorkiewicz, M. (2021). Hepatitis C Virus Uses Host Lipids to Its Own Advantage. Metabolites, 11.","DOI":"10.3390\/metabo11050273"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: Final update of the series","volume":"73","author":"Pawlotsky","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.3748\/wjg.v23.i13.2355","article-title":"Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1b","volume":"23","author":"Endo","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Hashimoto, S., Yatsuhashi, H., Abiru, S., Yamasaki, K., Komori, A., Nagaoka, S., Saeki, A., Uchida, S., Bekki, S., and Kugiyama, Y. (2016). Rapid Increase in Serum Low-Density Lipoprotein Cholesterol Concentration during Hepatitis C Interferon-Free Treatment. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0163644"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Peschel, G., Grimm, J., Gulow, K., Muller, M., Buechler, C., and Weigand, K. (2020). Chemerin Is a Valuable Biomarker in Patients with HCV Infection and Correlates with Liver Injury. Diagnostics, 10.","DOI":"10.3390\/diagnostics10110974"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1038\/s41598-021-93251-3","article-title":"Serum lipid profile in HCV patients treated with direct-acting antivirals: A systematic review and meta-analysis","volume":"11","author":"Villani","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1194\/jlr.D800028-JLR200","article-title":"Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry","volume":"50","author":"Wiesner","year":"2009","journal-title":"J. Lipid Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1194\/jlr.M800042-JLR200","article-title":"Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet","volume":"49","author":"Rinella","year":"2008","journal-title":"J. Lipid Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.bbamem.2017.04.006","article-title":"The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease","volume":"1859","author":"Kennelly","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrm2330","article-title":"Membrane lipids: Where they are and how they behave","volume":"9","author":"Voelker","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev-physiol-020518-114444","article-title":"Phospholipid Remodeling in Physiology and Disease","volume":"81","author":"Wang","year":"2019","journal-title":"Annu. Rev. Physiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1136\/gutjnl-2016-311508","article-title":"Lysophosphatidylcholine acyltransferase 1 is downregulated by hepatitis C virus: Impact on production of lipo-viro-particles","volume":"66","author":"Beilstein","year":"2017","journal-title":"Gut"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Haberl, E.M., Weiss, T.S., Peschel, G., Weigand, K., Kohler, N., Pauling, J.K., Wenzel, J.J., Horing, M., Krautbauer, S., and Liebisch, G. (2021). Liver Lipids of Patients with Hepatitis B and C and Associated Hepatocellular Carcinoma. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22105297"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Gobeil Odai, K., O\u2019Dwyer, C., Steenbergen, R., Shaw, T.A., Renner, T.M., Ghorbani, P., Rezaaifar, M., Han, S., Langlois, M.A., and Crawley, A.M. (2020). In Vitro Hepatitis C Virus Infection and Hepatic Choline Metabolism. Viruses, 12.","DOI":"10.3390\/v12010108"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Abomughaid, M., Tay, E.S.E., Pickford, R., Malladi, C., Read, S.A., Coorssen, J.R., Gloss, B.S., George, J., and Douglas, M.W. (2023). PEMT Mediates Hepatitis C Virus-Induced Steatosis, Explains Genotype-Specific Phenotypes and Supports Virus Replication. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24108781"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"9075","DOI":"10.1128\/JVI.00960-16","article-title":"Human Choline Kinase-alpha Promotes Hepatitis C Virus RNA Replication through Modulation of Membranous Viral Replication Complex Formation","volume":"90","author":"Wong","year":"2016","journal-title":"J. Virol."},{"key":"ref_19","first-page":"285","article-title":"The relationship between lipid profile and severity of liver damage in cirrhotic patients","volume":"10","author":"Ghadir","year":"2010","journal-title":"Hepat. Mon."},{"key":"ref_20","first-page":"OC15","article-title":"Association of Serum Lipids with Hepatic Steatosis, Stage of Liver Fibrosis and Viral Load in Chronic Hepatitis C","volume":"11","author":"Valkov","year":"2017","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1159\/000339206","article-title":"Lipid serum profile in patients with viral liver cirrhosis","volume":"21","author":"Vere","year":"2012","journal-title":"Med. Princ. Pract."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"100708","DOI":"10.1016\/j.aohep.2022.100708","article-title":"Position statement on the use of albumin in liver cirrhosis","volume":"27","author":"Bosques","year":"2022","journal-title":"Ann. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Horing, M., Peschel, G., Grimm, J., Krautbauer, S., Muller, M., Weigand, K., Liebisch, G., and Buechler, C. (2022). Serum Ceramide Species Are Associated with Liver Cirrhosis and Viral Genotype in Patients with Hepatitis C Infection. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23179806"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Peschel, G., Krautbauer, S., Weigand, K., Grimm, J., Horing, M., Liebisch, G., Muller, M., and Buechler, C. (2024). Rising Lysophosphatidylcholine Levels Post-Hepatitis C Clearance. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25021198"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0009-8981(75)90086-8","article-title":"Plasma and red blood cell phospholipids in chronic liver diseases","volume":"60","author":"Cantoni","year":"1975","journal-title":"Clin. Chim. Acta"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Meikle, P.J., Mundra, P.A., Wong, G., Rahman, K., Huynh, K., Barlow, C.K., Duly, A.M., Haber, P.S., Whitfield, J.B., and Seth, D. (2015). Circulating Lipids Are Associated with Alcoholic Liver Cirrhosis and Represent Potential Biomarkers for Risk Assessment. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0130346"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jhep.2016.01.003","article-title":"Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis","volume":"64","author":"McPhail","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1002\/elps.201200629","article-title":"Serum lipid profiling of patients with chronic hepatitis B, cirrhosis, and hepatocellular carcinoma by ultra fast LC\/IT-TOF MS","volume":"34","author":"Chen","year":"2013","journal-title":"Electrophoresis"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Virseda-Berdices, A., Rojo, D., Martinez, I., Berenguer, J., Gonzalez-Garcia, J., Brochado-Kith, O., Fernandez-Rodriguez, A., Diez, C., Hontanon, V., and Perez-Latorre, L. (2022). Metabolomic changes after DAAs therapy are related to the improvement of cirrhosis and inflammation in HIV\/HCV-coinfected patients. Biomed. Pharmacother., 147.","DOI":"10.1016\/j.biopha.2022.112623"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Weigand, K., Peschel, G., Grimm, J., Muller, M., Horing, M., Krautbauer, S., Liebisch, G., and Buechler, C. (2022). HCV Infection and Liver Cirrhosis Are Associated with a Less-Favorable Serum Cholesteryl Ester Profile Which Improves through the Successful Treatment of HCV. Biomedicines, 10.","DOI":"10.3390\/biomedicines10123152"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1111\/liv.15058","article-title":"Elastography is unable to exclude cirrhosis after sustained virological response in HCV-infected patients with advanced chronic liver disease","volume":"41","author":"Broquetas","year":"2021","journal-title":"Liver Int."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s40477-020-00456-9","article-title":"Alanine aminotransferase and spleno-portal dynamics affect spleen stiffness measured by point shear-wave elastography in patients with chronic hepatitis C in the absence of significant liver fibrosis","volume":"24","author":"Giuffre","year":"2020","journal-title":"J. Ultrasound"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3233\/CH-211193","article-title":"Liver stiffness assessed by shear-wave elastography declines in parallel with immunoregulatory proteins in patients with chronic HCV infection during DAA therapy","volume":"79","author":"Peschel","year":"2021","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Buechler, C., and Aslanidis, C. (2020). Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma. Biochim. Biophys. Acta-Mol. Cell Biol. Lipids, 1865.","DOI":"10.1016\/j.bbalip.2020.158658"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"101272","DOI":"10.1016\/j.diabet.2021.101272","article-title":"Management of diabetes mellitus in patients with cirrhosis: An overview and joint statement","volume":"47","author":"Boursier","year":"2021","journal-title":"Diabetes Metab."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest","volume":"46","author":"Mallet","year":"2007","journal-title":"Hepatology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"100067","DOI":"10.1016\/j.jhepr.2020.100067","article-title":"Limitations of non-invasive tests for assessment of liver fibrosis","volume":"2","author":"Patel","year":"2020","journal-title":"JHEP Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e00763","DOI":"10.14309\/crj.0000000000000763","article-title":"The Evolution of the MELD Score and Its Implications in Liver Transplant Allocation: A Beginner\u2019s Guide for Trainees","volume":"9","author":"Trivedi","year":"2022","journal-title":"ACG Case Rep. J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/JTO.0b013e3181ec173d","article-title":"Receiver operating characteristic curve in diagnostic test assessment","volume":"5","author":"Mandrekar","year":"2010","journal-title":"J. Thorac. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1590\/s0004-2803.201800000-33","article-title":"Increase of Lipids during Hcv Treatment: Virus Action or Medication?","volume":"55","author":"Andrade","year":"2018","journal-title":"Arq. Gastroenterol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s13337-020-00592-0","article-title":"HCV genotypes and their determinative role in hepatitis C treatment","volume":"31","author":"Keikha","year":"2020","journal-title":"Virusdisease"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1038\/s41598-022-09588-w","article-title":"Infection with the hepatitis C virus causes viral genotype-specific differences in cholesterol metabolism and hepatic steatosis","volume":"12","author":"Sheridan","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12944-022-01715-w","article-title":"Sex-specific changes in triglyceride profiles in liver cirrhosis and hepatitis C virus infection","volume":"21","author":"Peschel","year":"2022","journal-title":"Lipids Health Dis."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Kumarage, T., Morris, N.B., and Ashkar, R. (2023). The effects of molecular and nanoscopic additives on phospholipid membranes. Front. Phys., 11.","DOI":"10.3389\/fphy.2023.1251146"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1007\/s00261-019-02031-1","article-title":"Diagnostic accuracy of acoustic radiation force impulse elastography (ARFI) in comparison to other non-invasive modalities in staging of liver fibrosis in chronic HCV patients: Single-center experience","volume":"44","author":"Alem","year":"2019","journal-title":"Abdom. Radiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis\u20142021 update","volume":"75","author":"Berzigotti","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Xuan, Q., Hu, C., Zhang, Y., Wang, Q., Zhao, X., Liu, X., Wang, C., Jia, W., and Xu, G. (2022). Serum lipidomics profiles reveal potential lipid markers for prediabetes and type 2 diabetes in patients from multiple communities. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.966823"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/apt.13343","article-title":"Improvement of liver function parameters in advanced HCV-associated liver cirrhosis by IFN-free antiviral therapies","volume":"42","author":"Deterding","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/tri.12910","article-title":"Real-world experience with daclatasvir plus sofosbuvir +\/- ribavirin for post-liver transplant HCV recurrence and severe liver disease","volume":"30","author":"Herzer","year":"2017","journal-title":"Transpl. Int."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-6135.2004.00403.x","article-title":"Improving liver allocation: MELD and PELD","volume":"4","author":"Freeman","year":"2004","journal-title":"Am. J. Transplant."},{"key":"ref_51","first-page":"67","article-title":"Serum Marker Panels for Predicting Liver Fibrosis\u2014An Update","volume":"41","author":"Joseph","year":"2020","journal-title":"Clin. Biochem. Rev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"15074","DOI":"10.1038\/s41598-018-33536-2","article-title":"Current noninvasive liver reserve models do not predict histological fibrosis severity in hepatocellular carcinoma","volume":"8","author":"Ho","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/ajcn\/66.3.622","article-title":"Prolonged fasting in humans results in diminished plasma choline concentrations but does not cause liver dysfunction","volume":"66","author":"Savendahl","year":"1997","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3164\/jcbn.10-21","article-title":"The Alterations of Erythrocyte Phospholipids in Type 2 Diabetes Observed after Oral High-Fat Meal Loading: The FTIR Spectroscopic and Mass Spectrometric Studies","volume":"47","author":"Sirikwanpong","year":"2010","journal-title":"J. Clin. Biochem. Nutr."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.25653","article-title":"Review and management of drug interactions with boceprevir and telaprevir","volume":"55","author":"Kiser","year":"2012","journal-title":"Hepatology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1194\/jlr.P061143","article-title":"Statin action favors normalization of the plasma lipidome in the atherogenic mixed dyslipidemia of MetS: Potential relevance to statin-associated dysglycemia","volume":"56","author":"Meikle","year":"2015","journal-title":"J. Lipid Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"20150896","DOI":"10.1259\/bjr.20150896","article-title":"Morphometric changes in liver cirrhosis: Aetiological differences correlated with progression","volume":"89","author":"Ozaki","year":"2016","journal-title":"Br. J. Radiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ajg.2016.453","article-title":"Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis","volume":"112","author":"McPherson","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"100050","DOI":"10.1016\/j.jlr.2021.100050","article-title":"Accurate quantification of lipid species affected by isobaric overlap in Fourier-Transform mass spectrometry","volume":"62","author":"Horing","year":"2021","journal-title":"J. Lipid Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1021\/acs.analchem.0c02408","article-title":"Correction of Isobaric Overlap Resulting from Sodiated Ions in Lipidomics","volume":"92","author":"Horing","year":"2020","journal-title":"Anal. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Husen, P., Tarasov, K., Katafiasz, M., Sokol, E., Vogt, J., Baumgart, J., Nitsch, R., Ekroos, K., and Ejsing, C.S. (2013). Analysis of lipid experiments (ALEX): A software framework for analysis of high-resolution shotgun lipidomics data. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0079736"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1073274817729235","DOI":"10.1177\/1073274817729235","article-title":"Staging and Prognostic Models for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma","volume":"24","author":"Burkhart","year":"2017","journal-title":"Cancer Control"},{"key":"ref_64","first-page":"72","article-title":"Review Article on Parametric and Nonparametric Test","volume":"10","author":"Sharma","year":"2024","journal-title":"World J. Pharm. Med. Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/15\/8161\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:24:13Z","timestamp":1760109853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/15\/8161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,26]]},"references-count":64,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["ijms25158161"],"URL":"https:\/\/doi.org\/10.3390\/ijms25158161","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,26]]}}}